• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

0
Picture of 23andMe logo outside its California headquarters.
Tech23andMe users told to consider deleting their data by California attorney general as the company files for bankruptcy
By Beatrice NolanMarch 24, 2025
LifeThis company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’ 
By Alexa MikhailMarch 23, 2025
CommentaryMy son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By Michelle WernerMarch 10, 2025
Anne Wojcicki on stage at a conference
LeadershipA few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By Lila MacLellanMarch 1, 2025
Scientists working in a lab
FinanceInvestors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023
By Healthcare Brew and Maia AndersonJanuary 31, 2025
Sam Altman in suit and tie
HealthSam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
By Beth GreenfieldJanuary 24, 2025
As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic data of tens of millions of consented volunteers, health data startup Truveta announced Jan. 13, 2025.
HealthPharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By Lindsey LeakeJanuary 16, 2025
TechMerck snags Chinese obesity drug in nearly $2 billion deal
By Robert Langreth and BloombergDecember 18, 2024
Arnold Schwarzenegger is Zimmer Biomet’s inaugural chief movement officer.
HealthArnold Schwarzenegger is joining a Fortune 500 company to solve a great problem of his generation
By Lindsey LeakeNovember 13, 2024
Anne Wojcicki, chief executive officer and co-founder of 23andMe
Leadership23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
By Lila MacLellanOctober 17, 2024
HealthWill you live to 150? Here’s what 5 geneticists and aging researchers say
By Alexa MikhailOctober 6, 2024
HealthHow to delete your DNA data from 23andMe
By Alexa MikhailOctober 5, 2024
COVIDtests.gov will once again offer each U.S. household four free COVID-19 test kits beginning in late September 2024.
HealthFree, at-home COVID tests are back. Here’s how to order yours
By Lindsey LeakeSeptember 24, 2024
EnvironmentCalifornia firm grows cocoa from cell cultures as climate change threatens supply
By Amy Taxin, Terry Chea and The Associated PressSeptember 1, 2024
HealthSergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
By Marco Quiroz-GutierrezJuly 23, 2024
0
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.